CN115087729A - 赤红球菌细胞壁骨架在再生医学中的用途 - Google Patents

赤红球菌细胞壁骨架在再生医学中的用途 Download PDF

Info

Publication number
CN115087729A
CN115087729A CN202180005363.2A CN202180005363A CN115087729A CN 115087729 A CN115087729 A CN 115087729A CN 202180005363 A CN202180005363 A CN 202180005363A CN 115087729 A CN115087729 A CN 115087729A
Authority
CN
China
Prior art keywords
stem cells
mesenchymal stem
rhodococcus ruber
cell wall
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202180005363.2A
Other languages
English (en)
Other versions
CN115087729B (zh
Inventor
盖波
窦春艳
金培生
张轶
张国英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Greatest Bio Pharmaceutical Co Ltd
Original Assignee
Liaoning Greatest Bio Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Greatest Bio Pharmaceutical Co Ltd filed Critical Liaoning Greatest Bio Pharmaceutical Co Ltd
Publication of CN115087729A publication Critical patent/CN115087729A/zh
Application granted granted Critical
Publication of CN115087729B publication Critical patent/CN115087729B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

提供了赤红球菌细胞壁骨架在促进干细胞的增殖、促进干细胞的生长、促进干细胞的分化、促进干细胞的迁移、提高干细胞的存活率方面的用途；其中干细胞选自：成体干细胞、iPSC、间充质干细胞。

Description

PCT国内申请，说明书已公开。

Claims (13)

  1. PCT国内申请，权利要求书已公开。
CN202180005363.2A 2020-01-21 2021-01-20 赤红球菌细胞壁骨架在再生医学中的用途 Active CN115087729B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010068249 2020-01-21
CN2020100682491 2020-01-21
PCT/CN2021/072871 WO2021147899A1 (zh) 2020-01-21 2021-01-20 赤红球菌细胞壁骨架在再生医学中的用途

Publications (2)

Publication Number Publication Date
CN115087729A true CN115087729A (zh) 2022-09-20
CN115087729B CN115087729B (zh) 2024-06-28

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787931A (zh) * 2019-01-15 2020-10-16 辽宁格瑞仕特生物制药有限公司 分离的赤红球菌细胞壁骨架在制备治疗人乳头瘤病毒感染的药物中的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101384699A (zh) * 2005-12-21 2009-03-11 生物埃欧斯有限公司 产生粗糙型菌株的方法及其用途
CN108883134A (zh) * 2015-12-07 2018-11-23 科罗拉多州立大学研究基金会 活化干细胞和用于感染伤口的全身治疗方法
CN109666609A (zh) * 2019-01-14 2019-04-23 付家栋 一种赤红球菌发酵方法及其作为佐剂在动物疫苗中的应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101384699A (zh) * 2005-12-21 2009-03-11 生物埃欧斯有限公司 产生粗糙型菌株的方法及其用途
CN108883134A (zh) * 2015-12-07 2018-11-23 科罗拉多州立大学研究基金会 活化干细胞和用于感染伤口的全身治疗方法
CN109666609A (zh) * 2019-01-14 2019-04-23 付家栋 一种赤红球菌发酵方法及其作为佐剂在动物疫苗中的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ELEUTERIO LOMBARDO ET AL.: "Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential", TISSUE ENGINEERING PART A, vol. 15, pages 1 - 5 *
杨煌建等: "N-CWS对小鼠皮肤创伤愈合的影响", 中国抗生素杂志 *
苏亚楠等: "TLR2配体肽聚糖对骨髓间充质干细胞增殖和细胞周期的影响", 中国实验血液学杂志, vol. 18, no. 4, pages 987 *
饶桂强: "红色诺卡氏菌细胞壁骨架肽聚糖提取、鉴定及抗肿瘤实验研究", 中国优秀硕士学位论文全文数据库 医药卫生科技辑, pages 2 - 2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787931A (zh) * 2019-01-15 2020-10-16 辽宁格瑞仕特生物制药有限公司 分离的赤红球菌细胞壁骨架在制备治疗人乳头瘤病毒感染的药物中的用途

Also Published As

Publication number Publication date
US20230069441A1 (en) 2023-03-02
EP4043555A1 (en) 2022-08-17
JP2023510232A (ja) 2023-03-13
KR20220130162A (ko) 2022-09-26
EP4043555A4 (en) 2023-01-18
WO2021147899A1 (zh) 2021-07-29

Similar Documents

Publication Publication Date Title
CN111801105B (zh) 赤红球菌产品在治疗复发性阿弗他溃疡中的用途
US20220175852A1 (en) Use of rhodococcus ruber product in treating thermal injury
WO2020182180A1 (zh) 赤红球菌产品在治疗外阴白色病变中的用途
CN115087729B (zh) 赤红球菌细胞壁骨架在再生医学中的用途
WO2022199453A1 (zh) 赤红球菌产品在治疗放射病中的用途
CN115087729A (zh) 赤红球菌细胞壁骨架在再生医学中的用途
CN114402064A (zh) 红色诺卡氏菌细胞壁骨架在再生医学中的用途
US20130230494A1 (en) Cellular Preparations For Wound Management
CN111971054B (zh) 赤红球菌产品在治疗外阴白色病变中的用途
CN114470002B (zh) 胎盘间充质干细胞冻干粉在制备药物中的应用
CN117210395A (zh) 红色诺卡氏菌细胞壁骨架在皮瓣移植术中的用途
CN118236406A (zh) 赤红球菌产品在治疗温血动物的皮肤损伤或溃疡中的用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40072729

Country of ref document: HK

CB02 Change of applicant information

Address after: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant after: Liaoning Tian'an Biopharmaceutical Co.,Ltd.

Address before: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant before: LIAONING GREATEST BIO-PHARMACEUTICAL Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant